Sprague John M has filed 6 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 180000 shares of T2 Biosystems, Inc. ($TTOO) on November 04, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 4, 2024 | T2 Biosystems, Inc. | $TTOO | Sprague John M | CFO | A | Restricted Stock Units | 180000 | $0.00 | 180,000.0000 | 5,512,332 | 9999.99% | 3.27% |
| Nov. 4, 2024 | T2 Biosystems, Inc. | $TTOO | Sprague John M | CFO | A | Restricted Stock Units | 180000 | $0.00 | 180,000.0000 | 5,512,332 | 9999.99% | 3.27% |
| Feb. 24, 2024 | T2 Biosystems, Inc. | $TTOO | Sprague John M | Chief Financial Officer | M | Common Stock | 29 | $0.00 | 141.0000 | 0 | 25.89% | 0.00% |
| Feb. 24, 2024 | T2 Biosystems, Inc. | $TTOO | Sprague John M | Chief Financial Officer | M | Restricted Stock Units | 29 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 20, 2024 | T2 Biosystems, Inc. | $TTOO | Sprague John M | Chief Financial Officer | M | Common Stock | 40 | $0.00 | 112.0000 | 0 | 55.56% | 0.00% |
| Feb. 20, 2024 | T2 Biosystems, Inc. | $TTOO | Sprague John M | Chief Financial Officer | A | Restricted Stock Units | 40 | $0.00 | 40.0000 | 0 | 9999.99% | 0.00% |